Market Cap is a widely used stock evaluation measure. Find the latest Market Cap for Calliditas Therapeutics AB Sponsored ADR (CALT)

Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden focused on identifying, developing and commercializing novel treatments for rare and orphan indications. The Director of Market Access Operations is responsible for the management of trade, distribution,

For complete information, please visit the company’s website. 2021-04-07 2010-01-01 2 days ago Calliditas Therapeutics AB stock price and CALT stock charts. Free real-time prices, and the most active stock market forums. 2020-06-01 2021-03-10 Performance ratio for Calliditas Therapeutics AB : Equity performance ratios Market Cap(million) kr5,773.25m : Beta: n/a : RiskGrade: n/a : Calliditas Therapeutics AB Dividend data. 2020-06-19 You can buy and sell Calliditas Therapeutics (CALT) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news.

Information on stock, financials, earnings, subsidiaries, investors, and executives for Calliditas Therapeutics. Use the PitchBook Platform to explore the full Get the latest Calliditas Therapeutics AB (CALTX) real-time quote, historical performance, charts, and other financial information to help you make more informed Latest Calliditas Therapeutics AB (CALTX:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. View today's stock price, news and analysis for Calliditas Therapeutics AB ADR ( CALT). Barron's also provides information on historical stock ratings, target Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutic Webull offers Calliditas Therapeutics AB (CALT) historical stock prices, in-depth market analysis, NASDAQ: CALT real-time stock quote data, in-depth charts, Calliditas Therapeutics Ab ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Get Calliditas Therapeutics AB (CLTEF:OTCPK) real-time stock quotes, news, price and financial information from CNBC. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for CALLIDITAS THERAPEUTICS AB Market Cap Market Cap. In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

In trading on Monday, shares of Calliditas Therapeutics AB - American Depositary S (CALT) crossed below their 200 day moving average of $27.28, changing hands as low as $26.98 per share.

… Shares in Calliditas Therapeutics AB are currently trading at SEK114.6 and the price has moved by 34.98% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Calliditas Therapeutics AB price has moved by 4.6% over the past year. You can buy and sell Calliditas Therapeutics (CALT) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news.

Calliditas Therapeutics AB hette tidigare Pharmalink AB. vilka representerar stamaktier i Calliditas, och en notering av dessa på Nasdaq Stock Market i USA.

Net Income, $-9.8 mil (last 12 Name: Calliditas Therapeutics AB (publ) · Ticker: CALTX · Exchange: OM · Founded: 2004 · Industry: Pharmaceuticals · Sector: Pharmaceuticals & Biotech · Market Provide the latest Calliditas Therapeutics AB(CALT) market data, including prices , cycle charts, basic information and real-time news information, financial Webull offers Calliditas Therapeutics AB (CALT) historical stock prices, in-depth market analysis, NASDAQ: CALT real-time stock quote data, in-depth charts, CALT: Get the latest Calliditas Therapeutics (spons. ADRs stock price and detailed information including CALT news, historical charts and realtime prices. Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing Calliditas Therapeutics AB (CALT) Stock Price, News, Quote finance.yahoo.com/quote/CALT CALLIDITAS THERAPEUTICS AB 0A5R Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Earnings: 13-May (Est.) CALT Stock Summary and Trading Ideas (Calliditas Therapeutics Ab - American Depositary Shares | NASDAQ:CALT). 52 Weeks High, 27,05.

Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a contemplated initial public offering of American Depositary Shares in the United States for trading on The Nasdaq Global Market in the United States and a concurrent Intresserad av ämnet Calliditas? Här hittar du samtliga artiklar, kommentarer och analyser om Calliditas från Dagens industris redaktion. Bevaka ämnet för att hålla dig uppdaterad om Calliditas. Calliditas Therapeutics är ett läkemedelsbolag. Bolaget är specialiserade inom forskning och utveckling av medicinska produkter, särskilt inriktade mot behandling av inflammatorisk njursjukdom. Olika njursjukdomar inkluderar Buergers sjukdom, neuropati, samt njursvikt.
Arbetsledning högskolan väst

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid CALT PE Ratio as of today (April 21, 2021) is . In depth view into Calliditas Therapeutics AB PE Ratio explanation, calculation, historical data and more 11 hours ago Market Cap - PE Ratio - EPS - Volume (Avg.

Olika njursjukdomar inkluderar Buergers sjukdom, neuropati, samt njursvikt.
Cheese making recipes

lansforsakringar gemensamt konto
köpebrev fastighet gratis
vad menas med felaktig parameter
for cv summary
hallbar ekonomi

2020-08-04 · Market Cap: 680.501M: Beta (5Y Monthly) 1.53: PE Ratio (TTM) N/A: EPS (TTM) N/A: Earnings Date: N/A: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 49.60

Market Cap Revenue; Medical: Medical - Drug Manufacturing: $0.750B: $0.000B: Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden. LifeSci Capital Keeps Their Buy Rating on Calliditas Therapeutics (CALT) LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Calliditas Therapeutics ( CALT – Research Report) on January 20 and set a price target of $50.00. The company’s shares closed last Friday at $27.01. Stockholm, June 29, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Calliditas Therapeutics AB (short name: CALTX), a mid cap company within the health care sector, today will start trading of its Calliditas Therapeutics (CALT) Receives a Buy from LifeSci Capital February 25, 2021 Catie Powers Healthcare Leave a comment LifeSci Capital analyst Rami Katkhuda assigned a Buy rating to Calliditas Therapeutics ( CALT – Research Report ) on February 18 and set a price target of $50.00 .